CN109288764B - Hydrolat spray and preparation method thereof - Google Patents
Hydrolat spray and preparation method thereof Download PDFInfo
- Publication number
- CN109288764B CN109288764B CN201811481339.2A CN201811481339A CN109288764B CN 109288764 B CN109288764 B CN 109288764B CN 201811481339 A CN201811481339 A CN 201811481339A CN 109288764 B CN109288764 B CN 109288764B
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- spray
- phase
- hydrolat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007921 spray Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title description 5
- 239000000284 extract Substances 0.000 claims abstract description 57
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 41
- -1 glycerol glucoside Chemical class 0.000 claims abstract description 12
- UYZLQWUFBLEIAJ-UHFFFAOYSA-N [hydroxy(dimethyl)silyl] 2-hydroxybenzoate Chemical compound C[Si](C)(O)OC(=O)C1=CC=CC=C1O UYZLQWUFBLEIAJ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940023561 silanediol salicylate Drugs 0.000 claims abstract description 11
- 241001186295 Lespedeza capitata Species 0.000 claims abstract description 10
- 229930182478 glucoside Natural products 0.000 claims abstract description 10
- 239000003906 humectant Substances 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 9
- 239000003755 preservative agent Substances 0.000 claims abstract description 8
- 230000002335 preservative effect Effects 0.000 claims abstract description 8
- 241000723377 Coffea Species 0.000 claims abstract description 7
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 7
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 7
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 7
- 235000004727 Opuntia ficus indica Nutrition 0.000 claims abstract description 7
- 240000009297 Opuntia ficus-indica Species 0.000 claims abstract description 7
- 239000002562 thickening agent Substances 0.000 claims abstract description 7
- 239000001113 gentiana lutea root extract Substances 0.000 claims abstract description 6
- 229940082942 gentiana lutea root extract Drugs 0.000 claims abstract description 6
- 241000209490 Nymphaea Species 0.000 claims abstract description 5
- 244000181025 Rosa gallica Species 0.000 claims abstract 6
- 239000002994 raw material Substances 0.000 claims description 42
- 239000000203 mixture Substances 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 18
- 235000011187 glycerol Nutrition 0.000 claims description 17
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 15
- 229960005323 phenoxyethanol Drugs 0.000 claims description 15
- 239000003921 oil Substances 0.000 claims description 12
- YJCJVMMDTBEITC-UHFFFAOYSA-N 10-hydroxycapric acid Chemical compound OCCCCCCCCCC(O)=O YJCJVMMDTBEITC-UHFFFAOYSA-N 0.000 claims description 10
- 239000013535 sea water Substances 0.000 claims description 10
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 claims description 10
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 9
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 8
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 8
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 8
- 229960003237 betaine Drugs 0.000 claims description 8
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 8
- 229940101267 panthenol Drugs 0.000 claims description 8
- 235000020957 pantothenol Nutrition 0.000 claims description 8
- 239000011619 pantothenol Substances 0.000 claims description 8
- 229940109850 royal jelly Drugs 0.000 claims description 8
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 8
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 8
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 7
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 7
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 6
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 6
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 229940075529 glyceryl stearate Drugs 0.000 claims description 5
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 4
- FOTKYAAJKYLFFN-UHFFFAOYSA-N decane-1,10-diol Chemical compound OCCCCCCCCCCO FOTKYAAJKYLFFN-UHFFFAOYSA-N 0.000 claims description 4
- 229960000735 docosanol Drugs 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 3
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims description 3
- 229940074979 cetyl palmitate Drugs 0.000 claims description 3
- 230000003750 conditioning effect Effects 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims description 3
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- 229940110830 beheneth-25 methacrylate Drugs 0.000 claims 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims 1
- 229960002216 methylparaben Drugs 0.000 claims 1
- 230000005855 radiation Effects 0.000 abstract description 9
- 230000008439 repair process Effects 0.000 abstract description 9
- 239000005556 hormone Substances 0.000 abstract description 6
- 229940088597 hormone Drugs 0.000 abstract description 6
- 210000003491 skin Anatomy 0.000 description 35
- 230000000694 effects Effects 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 12
- 240000004978 Rosa x damascena Species 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 201000004624 Dermatitis Diseases 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 8
- 239000011148 porous material Substances 0.000 description 8
- 230000004054 inflammatory process Effects 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 4
- 206010040914 Skin reaction Diseases 0.000 description 4
- 230000027288 circadian rhythm Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 230000035483 skin reaction Effects 0.000 description 4
- 231100000430 skin reaction Toxicity 0.000 description 4
- 241000220317 Rosa Species 0.000 description 3
- 206010039792 Seborrhoea Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 230000028709 inflammatory response Effects 0.000 description 3
- 239000008132 rose water Substances 0.000 description 3
- 210000001732 sebaceous gland Anatomy 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 230000005808 skin problem Effects 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 229940114074 10-hydroxycapric acid Drugs 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000037312 oily skin Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 240000002022 Anthriscus cerefolium Species 0.000 description 1
- 235000007258 Anthriscus cerefolium Nutrition 0.000 description 1
- 102000004363 Aquaporin 3 Human genes 0.000 description 1
- 108090000991 Aquaporin 3 Proteins 0.000 description 1
- 102000010637 Aquaporins Human genes 0.000 description 1
- 108010063290 Aquaporins Proteins 0.000 description 1
- 208000017283 Bile Duct disease Diseases 0.000 description 1
- 241000743774 Brachypodium Species 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 241001249699 Capitata Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 206010008617 Cholecystitis chronic Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 101000588302 Homo sapiens Nuclear factor erythroid 2-related factor 2 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 241000522168 Kummerowia stipulacea Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 244000097724 Mesua ferrea Species 0.000 description 1
- 235000010931 Mesua ferrea Nutrition 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 102100031701 Nuclear factor erythroid 2-related factor 2 Human genes 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000005704 Olneya tesota Nutrition 0.000 description 1
- 240000001439 Opuntia Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 235000008198 Prosopis juliflora Nutrition 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 239000010404 Scutellaria baicalensis extract Substances 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000222 aromatherapy Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229940059958 centella asiatica extract Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- INSRQEMEVAMETL-UHFFFAOYSA-N decane-1,1-diol Chemical compound CCCCCCCCCC(O)O INSRQEMEVAMETL-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000002169 hydrotherapy Methods 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000001331 rosmarinus officinalis leaf Substances 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
The invention provides a hydrolat spray which comprises the following components in parts by weight: 0.01-3 parts of glycerol glucoside, 0.01-5 parts of Gentiana lutea root extract, 0.01-5 parts of Opuntia ficus indica stem extract, 0.1-5 parts of silanediol salicylate, 0.01-5 parts of Lespedeza capitata leaf/stem extract, 0.01-5 parts of Coffea fruticosa seed extract, 0.01-3 parts of Egyptian Nymphaea flower extract, 0.01-3 parts of snow lotus flower extract, 0.001-0.5 part of Rosa damascena flower oil, 0.1-25 parts of humectant, 0.01-31 parts of skin conditioner, 0.1-1 part of thickener, 0.01-0.05 part of pH regulator, 0.5-10 parts of spray improver, 0.01-3.2 parts of preservative and 0.01-2 parts of solubilizer. The hydrolat spray can effectively resist blue light and ultraviolet radiation of computers and mobile phones and effectively repair hormone faces.
Description
Technical Field
The invention relates to the technical field of skin care products, in particular to a hydrolat spray and a preparation method thereof.
Background
The skin is the largest organ of the human body and functions to protect various tissues and organs in the body from physical, mechanical, chemical and pathogenic microbial attack. The appearance of the skin is related to the water content of the stratum corneum, which normally contains 10-30% water to maintain the softness and elasticity of the skin. At present, most modern women work in the air-conditioned room, make facial skin dry easily, tight, situation such as coarse and desquamation to form dry line, cause a great deal of skin problem, use computer and cell-phone for a long time simultaneously, the pore that leads to is big, and the skin that blue light radiation arouses is excessively ageing. But also because of skin irritation and hormonal face problems when improper cosmetics are used.
Most of the existing commercially available sprays aim at moisturizing, and few sprays can simultaneously moisturize and resist skin inflammation caused by blue light and ultraviolet light, so that the development of a spray which can moisturize and repair skin problems caused by blue light and ultraviolet light is urgently needed.
Disclosure of Invention
The invention provides the spray which is convenient to use, can preserve moisture and repair skin problems caused by blue light and ultraviolet light to make up for the defects of the prior art.
In order to realize the purpose of the invention, the technical scheme adopted by the invention is as follows: a hydrolat spray comprises the following components in parts by weight: 0.01-3 parts of glycerol glucoside, 0.01-5 parts of Gentiana lutea root extract, 0.01-5 parts of Opuntia ficus indica stem extract, 0.1-5 parts of silanediol salicylate, 0.01-5 parts of Lespedeza capitata leaf/stem extract, 0.01-5 parts of Coffea fruticosa seed extract, 0.01-3 parts of Egyptian Nymphaea flower extract, 0.01-3 parts of snow lotus flower extract, 0.001-0.5 part of Rosa damascena flower oil, 0.1-25 parts of humectant, 0.01-31 parts of skin conditioner, 0.1-1 part of thickener, 0.01-0.05 part of pH regulator, 0.5-10 parts of spray improver, 0.01-3.2 parts of preservative and 0.01-2 parts of solubilizer.
Preferably, the hydrosol spray comprises the following components in parts by weight: 0.2-1 part of glycerol glucoside, 0.1-1 part of Gentiana lutea root extract, 0.5-1 part of opuntia ficus indica stem extract, 1-4 parts of silanediol salicylate, 1-4 parts of Lespedeza capitata leaf/stem extract, 1-4 parts of Coffea pipiens seed extract, 1-4 parts of Egyptian Nymphaea flower extract, 1-4 parts of snow lotus extract, 0.002-0.2 part of Rosa damascena flower oil, 3-18 parts of humectant, 2-20 parts of skin conditioner, 0.1-1 part of thickener, 0.01-0.05 part of pH regulator, 0.5-10 parts of spray improver, 0.5-1.6 parts of preservative and 0.01-2 parts of solubilizer.
Preferably, the skin conditioning agent is selected from one or any combination of panthenol, sodium hyaluronate, rosa damascena flower water and royal jelly.
More preferably, the skin conditioner comprises the following components in parts by weight: 0.01-5 parts of panthenol, 0.01-1 part of sodium hyaluronate, 0.5-20 parts of rosa damascena flower water and 0.01-5 parts of royal jelly; the Royal Jelly is a mixture of butanediol, Royal Jelly, 10-hydroxydecanoic acid, sebacic acid and 1, 10-decanediol, and is a product raw material of Royal Jelly oil control factor from the company of Provision Group under the trade name of AC Royal Jelly Extract.
Preferably, the humectant is selected from one or any combination of butylene glycol, betaine, seawater, phenoxyethanol and ethylhexyl glycerin.
More preferably, the humectant comprises the following components in parts by weight: 0.1-10 parts of butanediol, 0.01-5 parts of betaine, 0.1-20 parts of seawater, a mixture of phenoxyethanol and ethylhexyl glycerol; wherein the mixture of seawater, phenoxyethanol and ethylhexylglycerin is a product raw material from Ironwood Clay company under the trade name of GLACIAL MINERAL WATER-PE glacier mineral water.
Preferably, the thickener is an acrylic acid (ester)/behenyl alcohol polyether-25 methacrylate copolymer.
Preferably, the pH agent is triethanolamine.
Preferably, the preservative is one of methyl hydroxybenzoate, phenoxyethanol, ethylhexyl glycerol and 1, 2-hexanediol or any combination thereof.
More preferably, the preservative comprises the following components in parts by weight: 0.01-0.2 part of methyl hydroxybenzoate, 0.05-1 part of a mixture of phenoxyethanol and ethylhexylglycerin, and 0.1-2 parts of 1, 2-hexanediol; wherein the mixture of phenoxyethanol and ethylhexyl glycerol is a product raw material from Schulke Mayr GmbH (Shumei, Germany) under the trade name EUXYL PE 9010.
Preferably, the spray improver is cetearyl isononanoate, cetearyl alcohol, glyceryl stearate, ceteareth-12, cetyl palmitate, and a mixture of glycerol, available from STEPHENSON under the tradename WINEMUL Yes.
Preferably, the solubilizer is PEG-40 hydrogenated castor oil, a raw material product from BASF corporation under the trade name Eumulgin CO 40.
The invention also provides a preparation method for preparing the hydrolat spray, which comprises the following steps:
(1) sequentially adding the phase A raw materials into an emulsifying pot, starting stirring and heating, sequentially adding the phase B raw materials, and uniformly stirring until the mixture is transparent; then, sequentially adding the C-phase raw materials, heating to 80-85 ℃, uniformly stirring, keeping the temperature for 30 minutes, finally adding the dispersed D-phase raw materials, uniformly stirring, and cooling; wherein the phase A raw material comprises water, acrylic acid (ester)/behenyl alcohol polyether-25 methacrylate copolymer; the phase B raw material is triethanolamine; the C phase raw material comprises butanediol, betaine, panthenol, methyl hydroxybenzoate, sodium hyaluronate, and flos Rosae Davuricae water; phase D materials including cetearyl isononanoate, cetearyl alcohol, glyceryl stearate, ceteareth-12, a mixture of cetearyl palmitate and glycerin, and water;
(2) when the temperature is reduced to 45 ℃, sequentially adding the E-phase raw materials, and uniformly stirring; wherein the raw materials of phase E comprise glycerol glucoside, radix Gentianae extract, caulis et folium Opuntiae Dillenii extract, butanediol, Lac Regis Apis, 10-hydroxydecanoic acid, sebacic acid, 1, 10-decanediol, seawater/phenoxyethanol/ethylhexyl glycerol, silanediol salicylate, Lespedeza capitata leaf/stem extract, semen Caucae Caucalli extract, Egyptian flos Nymphaeae extract, and herba Saussureae Involueratae extract;
(3) adding the F-phase raw material and the G-phase raw material in sequence, mixing until the mixture is transparent, and stirring for at least 20 minutes until the mixture is uniform; wherein the F phase raw material comprises phenoxyethanol, ethylhexyl glycerol and 1, 2-hexanediol; the G phase raw material comprises Rosa damascena flower oil and a solubilizer.
(4) After sampling and detection are qualified, filtering and discharging at 38 ℃ to obtain the hydrolat spray.
The rosa damascena flower water selected by the invention has obvious functions of relieving and tonifying the nervous system, so that the rosa damascena flower water is widely applied to hydrotherapy, sauna and aromatherapy and the manufacture of cream, ointment, shower gel and bubble gel. It has strong sedative and stress relieving effects, and scientific evidence shows that the smell of rose water can enhance memory and stimulate the thinking process of human beings. Ophthalmologists recommend rinsing the eyes with rose water, which is particularly useful for people who work in front of computer screens for long periods of time. In addition, dentists also recommend rinsing with rose water to treat oral inflammation.
The natural betaine is an amino acid humectant, and has effects of regulating water balance, protecting cells, reducing mechanical, chemical and biological irritation to cells, and strengthening skin barrier layer to make skin have better skin feeling.
The panthenol is colorless transparent high viscosity liquid, can deeply moisten and moisturize skin, stimulate epithelial cell growth, and has wound healing and anti-inflammatory effects.
Glycerol glucoside is a natural cell activator and can enhance cell activity and metabolism, activate skin regeneration cells, enhance oxidation resistance (SOD) of skin cells, accelerate synthesis of type I collagen precursor in aging cells, increase skin moisture retention, elasticity, smoothness and skin thickness, relieve skin redness, resist erythema, and accelerate wound healing and tissue repair.
The Gentiana lutea root extract can inhibit cyclooxygenase activity, inhibit skin pigmentation due to inflammatory reaction caused by ultraviolet, and relieve irritation of surfactant.
The cactus is a crop which is cultivated long ago, and plays an important role in agricultural economy in arid and semiarid regions all over the world. The most commercially valuable use of opuntia ficus-indica comes from its large and sweet fruit, the tuna opuntia fruit. The fruit of Opuntia ficus-indica contains vitamin C, and can be used as an early treatment method of scurvy.
10-hydroxy capric acid (10-HAD), sebacic acid, decanediol, etc. in Lac Regis Apis can effectively reduce the number of active sebaceous glands, reduce sebum secretion of active sebaceous glands, and strongly inhibit acne bacteria. Experiments prove that: the secretion of skin grease can be obviously reduced within 1 hour, and the effect lasts for more than 6 hours; long-term application without any skin resistance and side effects; the traditional Chinese medicine composition can be used for mildly inhibiting bacteria, removing acnes doubly, and effectively controlling and relieving seborrheic alopecia.
Glacier mineral water (seawater/phenoxyethanol/ethylhexylglycerin) is an essence extracted from natural sea mud, and is prepared by using a 100% natural extraction process. Contains rich elements and rare earth elements, and really embodies the complex composition and the efficacy of the natural sea mud. Clear and transparent aqueous solutions, suitable for use in all personal care formulations, provide a natural balance of mineral elements. Used in physical sunscreen formulations to provide SPF boosting.
The silanediol salicylate can participate in the communication between keratinocytes and fibroblasts, and helps the skin to improve the natural resistance, so that the effects of skin soothing and inflammation diminishing are achieved, and the silanediol salicylate has good anti-inflammation and anti-free radical capabilities. Can be used for anti-acne, sun protection and after-sun repair, after-shave skin care, sensitive skin and infant products. It can also be used in hair care products to relieve inflammation caused by seborrhea, and increase dosage can promote hair metabolism.
The Lespedeza capitata leaf/stem extract is extracted from wild Korean Lespedeza capitata (Lespedeza capitata), is a long-history traditional Chinese herbal medicine in the United states and Asia, is also called as Trifolium bulleyana planifolia, belongs to leguminous plants, effectively resets circadian rhythms, effectively regulates circadian rhythm-dependent biological functions such as aquaporin-3 (aquaporins), enhances the action effect of a rhythm-related Nrf2 detoxification system, and regulates blue light-mediated oxidative stress.
The natural active ingredients of the small-fruit coffee seed extract are obtained in an environment-friendly manner, can effectively absorb blue light radiation, resist electronic pollution and protect multiple functions.
The petals and stamens of the lotus are rich in various active ingredients, and have good moisturizing effect. The lotus extract brings feeling of skin water saturation and protection, makes skin clean, moist and fresh, and has the effect of relaxing spirit when being used for SPA.
The Rosa damascena flower oil is one of rose essential oils, and can restore sebaceous gland function, eliminate edema, heal wound, and treat dermatitis, neurodermatitis, allergy, arthritis and rheumatism. In the medical field, rose essential oil can be used for treating chronic cholecystitis, bile duct diseases and asthma. The rose essential oil is also useful for relieving nervous system disorders, treating gastrointestinal disorders and improving sexual dysfunction.
The invention has the beneficial effects that: according to the invention, the extract of the cotyledon/stem of the brachypodium capitatum is compounded with the extract of the coffee chervil seed, so that blue light and ultraviolet radiation of computers and mobile phones can be effectively resisted, and meanwhile, the gentian extract is added, so that inflammation caused by ultraviolet radiation can be effectively resisted; the glycerol glucoside and the silanediol salicylate are compounded, so that the hormone face can be effectively repaired, and the skin with the damaged normal physiological structure can be repaired; the glacier mineral water can activate high-concentration dissolved ions with cell activity and enhance the activity and biological functions of active ingredients in the skin care formula. Meanwhile, various oil-controlling and oxidation-resisting components are added, so that oil control, acne removal and pore contraction are effectively achieved.
Detailed Description
In order to more concisely and clearly demonstrate technical solutions, objects and advantages of the present invention, the present invention will be further described in detail with reference to specific embodiments.
Examples 1-5 formulations of the hydrolat spray, as shown in table 1:
example 6
The embodiment provides a preparation method of a hydrosol spray, which comprises the following steps:
(1) sequentially adding the phase A into an emulsifying pot, stirring and heating, sequentially adding the phase B raw materials, and uniformly stirring until the mixture is transparent; then, sequentially adding the C-phase raw materials, heating to 80-85 ℃, uniformly stirring, keeping the temperature for 30 minutes, finally adding the dispersed D-phase raw materials, uniformly stirring, and cooling; wherein the phase A raw material comprises water, acrylic acid (ester)/behenyl alcohol polyether-25 methacrylate copolymer; the phase B raw material is triethanolamine; the C phase raw material comprises butanediol, betaine, panthenol, methyl hydroxybenzoate, sodium hyaluronate, and flos Rosae Davuricae water; phase D materials including cetearyl isononanoate, cetearyl alcohol, glyceryl stearate, ceteareth-12, a mixture of cetearyl palmitate and glycerin, and water;
(2) when the temperature is reduced to 45 ℃, sequentially adding the E-phase raw materials, and uniformly stirring; wherein the raw materials of phase E comprise glycerol glucoside, radix Gentianae extract, caulis et folium Opuntiae Dillenii extract, butanediol, Lac Regis Apis, 10-hydroxydecanoic acid, sebacic acid, 1, 10-decanediol, seawater/phenoxyethanol/ethylhexyl glycerol, silanediol salicylate, Lespedeza capitata leaf/stem extract, semen Caucae Caucalli extract, Egyptian flos Nymphaeae extract, and herba Saussureae Involueratae extract;
(3) adding the F-phase raw material and the G-phase raw material in sequence, mixing until the mixture is transparent, and stirring for at least 20 minutes until the mixture is uniform; wherein the F phase raw material comprises phenoxyethanol, ethylhexyl glycerol and 1, 2-hexanediol; the G phase raw material comprises Rosa damascena flower oil and a solubilizer.
(4) After sampling and detection are qualified, filtering and discharging at 38 ℃ to obtain the hydrolat spray.
Comparative example 1
Comparative example 1 is a similar product to the spray of the invention, comprising the following components by weight: 3-15 parts of rosa damascena flower water, 1-10 parts of seawater, 0.1-2 parts of cetearyl alcohol, 0.1-2 parts of cetyl palmitate, 0.5-3 parts of trehalose, 261-4 parts of glyceryl polyether, 1-8 parts of 1, 3-propylene glycol, 0.01-0.3 part of sodium hyaluronate, 0.01-0.3 part of peony root extract, 0.1-2 parts of centella asiatica extract, 0.1-2 parts of glycyrrhiza glabra root extract, 0.1-1 part of polygonum cuspidatum root extract, 0.1-3 parts of scutellaria baicalensis extract, 0.1-3 parts of chamomile chrysanthemum extract, 0.1-1 part of tea extract, 0.1-1 part of rosemary leaf extract, 0.3-2 parts of camellia extract and the like.
Examples 1-5 were sprayed (wherein examples 1-5 were prepared according to the method of example 6) for safety and efficacy evaluation, and the experimental methods were as follows:
first, the skin patch test
Number of test population: 150 persons; age: between 20-50 years old; health condition: the tested skin is healthy, has no allergic history of the skin disease and meets the voluntary selection standard of the tested subject. The total number was 10 groups of 15 people each.
The spot pasting method comprises the following steps: selecting a qualified spot tester, dripping 0.020 g-0.025 g of a tested object into the spot tester in a closed spot patch test mode, externally applying a special adhesive tape to the back of the tested object, removing the tested object after 24 hours, observing skin reactions after 0.5, 6, 12, 24 and 48 hours after the tested object is removed respectively, and recording the results according to the skin reaction grading standard in the cosmetic hygiene standard.
And (3) test results:
the result of the human body skin patch test shows that: each group of subjects observed skin reactions at 0.5, 6, 12, 24, 48 hours by the lotion spray patch test of the invention of examples 1-5, of which 0 had adverse skin reactions, indicating that the lotion spray of the invention was safe to use.
Secondly, effect detection:
1. effect of resisting blue light and ultraviolet radiation
Blue light and ultraviolet radiation as a circadian rhythm disrupter, with certain concentrations of the example samples of the invention added, effectively inhibit oxidation phenomena caused by circadian rhythm disruption (blue light), and provide skin protection by reducing free radicals produced by ultraviolet radiation-induced oxidative stress.
Experimental method 10 female volunteers (33-55 years old, average age 43 years old) were selected for each experimental group, samples of the comparative examples and examples of the present invention were applied to the face, and from 7 pm, the volunteers watched an artificial light curtain (tablet computer) at home for 1 month continuously, and skin color was measured by colorimetry using a goniospectrophotometer. The device can characterize the main aspects of the skin: lightness/dullness, color and surface condition. The results are shown in table 2:
table 2: results for skin lightness/dullness, skin tone enhancement for subjects from examples 1-5, comparative example 1 (same type of contestant)
2. Anti-inflammatory effects:
ultraviolet radiation can trigger an inflammatory response in the skin. NF-kb (transcription factor) is known to be a main regulatory protein in inflammatory response of the body, and controls the production and release of various inflammatory protein factors. Many actives exert anti-inflammatory effects by inhibiting NF-kb. NF-kb is used as an inflammation marker, and inflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) or interleukin and the like are used for stimulating human keratinocytes, activating the NF-kb and inducing cell inflammation reaction. The cells were treated by adding a certain concentration of the samples of the examples and comparative examples of the present invention, and their ability to inhibit NF-kb expression was observed.
The specific test mode is as follows: 10 volunteers aged 20-50 years, who often go out and move and are deeply irradiated by ultraviolet rays are selected from each experimental group; the using method comprises the following steps: about 2 grams of the inventive example, comparative example, and sample were applied to the face once a day. And taking pictures and archiving after 1 month. By comparing the data from examples 1-5 with that from comparative example 1, the percent inhibition of the inflammatory response of the cells by the agent can be obtained and the results are shown in Table 3:
table 3: results of NF-kb inhibition rates of examples 1-5 and comparative example 1 (same type of competitors)
3. Restoring hormonal face effects
Hormone-dependent dermatitis is a short term for corticosteroid-hormone-dependent dermatitis, and is dermatitis caused by long-term inappropriate external hormones.
The experimental method comprises the steps that 10 female volunteers (25-35 years old and 28 years old in average age) are selected from each experimental group, the experimental group and the competitive sample are used for being smeared on the face for 1 month continuously, the repair effect of the hormone face is observed, and the repair rate is shown in table 4.
Table 4: results of hormone face repair in examples 1-5 and comparative example 1 (same type of competition)
| Subject number | Example 1 | Example 2 | Example 3 | Example 4 | Example 5 | Comparative example 1 |
| 1 | 62.2 | 90.3 | 30.5 | 21.4 | 62.5 | 49.5 |
| 2 | 60.2 | 86.2 | 20.5 | 29.5 | 51.5 | 40.6 |
| 3 | 53.6 | 85.6 | 34.1 | 27.4 | 42.6 | 35.4 |
| 4 | 63.2 | 81.4 | 33.1 | 34.8 | 62.1 | 45.5 |
| 5 | 65.8 | 89.3 | 20.8 | 26.5 | 50.8 | 40.3 |
| 6 | 66.9 | 95.1 | 32.9 | 45.2 | 64.9 | 41.7 |
| 7 | 50.1 | 86.4 | 29.1 | 30.4 | 61.2 | 42.5 |
| 8 | 59.1 | 91.8 | 30.5 | 38.2 | 54.1 | 45.7 |
| 9 | 65.1 | 94.4 | 34.1 | 35.4 | 64.4 | 40.3 |
| 10 | 63.8 | 93.6 | 20.7 | 37.2 | 42.7 | 35.0 |
| Average repair ratio (%) | 68.8 | 89.41 | 28.63 | 32.6 | 55.68 | 41.65 |
4. Oil controlling and pore shrinking effects
Sebum adjustment test: in vitro test method 2 groups of 20 (male and female) oily skin or mixed skin (between 18 and 55 years old) were selected for comparison with the comparative examples of the invention, applied 2 times a day for 30 days by
Sebum tests were performed on the forehead and the results are shown in table 5:
table 5: EXAMPLES 1-5 AND COMPARATIVE EXAMPLE 1 (COMPARATIVE PROPERTIES) MODULATION OF sebum TEST RESULTS
5. Number of pores and pore diameter and volume reduction effect test
Test method 2 group 20 (male and female) oily skin or mixed skin (between 18-55 years) was compared to placebo, market contestants, smeared 2 times a day and self-assessed using 30 days to measure the apparent pores (>0.25mm) around the cheeks and nose by image analysis (ratio meter), with results as shown in table 6:
table 6: results of testing the number of pores in examples 1 to 5 and comparative example 1 (similar competitive products)
As can be seen from tables 2 to 6, examples 1,2 and 5 all had the effect of resisting blue light, and the skin brightness of the subject was significantly improved, effectively inhibited skin inflammation, and helped the subject alleviate discomfort symptoms caused by skin inflammation, and also had significant repair effects on hormonal facial symptoms, and could effectively control oil and shrink pores. Examples 3, 4 and comparative example 1 did not improve the brightness of the skin of the subject and reduced the degree of inflammation of the skin of the subject due to the lack of the corresponding ingredients of the present invention in examples 3, 4.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.
Claims (10)
1. The hydrolat spray is characterized by comprising the following components in parts by weight: 0.01-3 parts of glycerol glucoside, 0.01-5 parts of Gentiana lutea root extract, 0.01-5 parts of Opuntia ficus indica stem extract, 0.1-5 parts of silanediol salicylate, 0.01-5 parts of Lespedeza capitata leaf/stem extract, 0.01-5 parts of Coffea fruticosa seed extract, 0.01-3 parts of Egyptian Nymphaea flower extract, 0.01-3 parts of snow lotus flower extract, 0.001-0.5 part of Rosa damascena flower oil, 0.1-25 parts of humectant, 0.01-31 parts of skin conditioner, 0.1-1 part of thickener, 0.01-0.05 part of pH regulator, 0.5-10 parts of spray improver, 0.01-3.2 parts of preservative and 0.01-2 parts of solubilizer.
2. The hydrosol spray of claim 1, comprising the following components in parts by weight: 0.2-1 part of glycerol glucoside, 0.1-1 part of Gentiana lutea root extract, 0.5-1 part of opuntia ficus indica stem extract, 1-4 parts of silanediol salicylate, 1-4 parts of Lespedeza capitata leaf/stem extract, 1-4 parts of Coffea pipiens seed extract, 1-3 parts of Egyptian Nymphaea flower extract, 1-3 parts of snow lotus extract, 0.002-0.2 part of Rosa damascena flower oil, 3-18 parts of humectant, 2-20 parts of skin conditioner, 0.1-1 part of thickener, 0.01-0.05 part of pH regulator, 0.5-10 parts of spray improver, 0.5-1.6 parts of preservative and 0.01-2 parts of solubilizer.
3. The lotion spray of claim 1 or 2, wherein the skin conditioning agent is selected from the group consisting of panthenol, sodium hyaluronate, rosa damascena water, royal jelly, and any combination thereof.
4. The lotion spray of claim 3, wherein the skin conditioning agent comprises the following components in parts by weight: 0.01-5 parts of panthenol, 0.01-1 part of sodium hyaluronate, 0.5-20 parts of rosa damascena flower water and 0.01-5 parts of royal jelly.
5. The hydrolat spray of claim 1, wherein the humectant is selected from one or any combination of butylene glycol, betaine, seawater, ethylhexylglycerin.
6. The hydrolat spray of claim 1 or 5, wherein the humectant comprises the following components in parts by weight: 0.1-10 parts of butanediol; 0.01-5 parts of betaine; 0.1-20 parts of a mixture of seawater, phenoxyethanol and ethylhexylglycerin.
7. The hydrolat spray of claim 1, wherein the thickener is an acrylic acid (ester)/beheneth-25 methacrylate copolymer.
8. The hydrolat spray of claim 1, wherein the preservative is one of methylparaben, phenoxyethanol, ethylhexylglycerin, 1, 2-hexanediol, or any combination thereof.
9. The hydrolat spray of claim 1 or 8 wherein the spray improver is a mixture of cetearyl isononanoate, cetearyl alcohol, glyceryl stearate, ceteareth-12, cetyl palmitate and glycerol.
10. A method of preparing a hydrolat spray as claimed in any one of claims 1 to 9, comprising the steps of:
(1) sequentially adding the phase A raw materials into an emulsifying pot, starting stirring and heating, sequentially adding the phase B raw materials, and uniformly stirring until the mixture is transparent; then, sequentially adding the C-phase raw materials, heating to 80-85 ℃, uniformly stirring, keeping the temperature for 30 minutes, finally adding the dispersed D-phase raw materials, uniformly stirring, and cooling; wherein the phase A raw material comprises water, acrylic acid (ester)/behenyl alcohol polyether-25 methacrylate copolymer; the phase B raw material is triethanolamine; the C phase raw material comprises butanediol, betaine, panthenol, methyl hydroxybenzoate, sodium hyaluronate, and flos Rosae Davuricae water; phase D materials including cetearyl isononanoate, cetearyl alcohol, glyceryl stearate, ceteareth-12, a mixture of cetearyl palmitate and glycerin, and water;
(2) when the temperature is reduced to 45 ℃, sequentially adding the E-phase raw materials, and uniformly stirring; wherein the raw materials of phase E comprise glycerol glucoside, radix Gentianae extract, caulis et folium Opuntiae Dillenii extract, butanediol, Lac Regis Apis, 10-hydroxydecanoic acid, sebacic acid, 1, 10-decanediol, seawater/phenoxyethanol/ethylhexyl glycerol, silanediol salicylate, Lespedeza capitata leaf/stem extract, semen Caucae Caucalli extract, Egyptian flos Nymphaeae extract, and herba Saussureae Involueratae extract;
(3) adding the F-phase raw material and the G-phase raw material in sequence, mixing until the mixture is transparent, and stirring for at least 20 minutes until the mixture is uniform; wherein the F phase raw material comprises phenoxyethanol, ethylhexyl glycerol and 1, 2-hexanediol; the raw material of the G phase comprises rosa damascena flower oil and a solubilizer;
(4) filtering and discharging at 38 ℃ to obtain the hydrosol spray.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811481339.2A CN109288764B (en) | 2018-12-05 | 2018-12-05 | Hydrolat spray and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811481339.2A CN109288764B (en) | 2018-12-05 | 2018-12-05 | Hydrolat spray and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109288764A CN109288764A (en) | 2019-02-01 |
| CN109288764B true CN109288764B (en) | 2021-09-07 |
Family
ID=65142628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811481339.2A Active CN109288764B (en) | 2018-12-05 | 2018-12-05 | Hydrolat spray and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109288764B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109939058B (en) * | 2019-04-19 | 2022-02-18 | 广州萝薇化妆品有限公司 | Blue-light-proof cosmetic composition and preparation method thereof |
| CN110236967B (en) * | 2019-06-21 | 2021-10-08 | 广州艾蓓生物科技有限公司 | Acne removing gel |
| CN110960468B (en) * | 2020-01-09 | 2022-06-24 | 伊尔瑞生物科技(江苏)有限公司 | Preparation method of anti-aging and anti-blue-light cosmetic containing plant extract |
| CN111671710A (en) * | 2020-07-31 | 2020-09-18 | 重庆康视美科技有限公司 | Blue-light-resistant eye-protecting skin lotion as well as preparation method and use method thereof |
| CN112603868B (en) * | 2021-01-04 | 2023-01-10 | 完美（广东）日用品有限公司 | Application of gentian root extract, composition containing gentian root extract, cosmetics and preparation method of cosmetics |
| CN113576986A (en) * | 2021-09-14 | 2021-11-02 | 广州碧涛化妆品有限公司 | Washing-free water-based spray type hair conditioner and preparation method thereof |
| CN115212148B (en) * | 2022-07-22 | 2023-08-11 | 广州睿森生物科技有限公司 | Acne removing composition and application thereof |
| CN116139044A (en) * | 2022-12-27 | 2023-05-23 | 广州市瑞芬化妆品有限公司 | Moisturizing lotion spray and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013173730A (en) * | 2012-01-24 | 2013-09-05 | Rohto Pharmaceutical Co Ltd | Whitening composition |
| CN106333917A (en) * | 2016-10-09 | 2017-01-18 | 上海兰葹生物科技有限公司 | Dendrobium nobile skin regeneration promotion combination essence |
| CN107375090A (en) * | 2017-08-15 | 2017-11-24 | 广州艾蓓生物科技有限公司 | Rose water light flesh bottom spraying and preparation method thereof |
-
2018
- 2018-12-05 CN CN201811481339.2A patent/CN109288764B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN109288764A (en) | 2019-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109288764B (en) | Hydrolat spray and preparation method thereof | |
| KR101509608B1 (en) | Composition for improving scalp and hair condition | |
| KR101860496B1 (en) | Composition containing extract of venus flytrap for cosmetic treatment | |
| CN112494406A (en) | Whitening and freckle-removing cosmetic and preparation method thereof | |
| CN103237555A (en) | Topical skin care formulation | |
| CN110279599B (en) | Whitening composition, set containing whitening composition and preparation method of set | |
| US20130101689A1 (en) | Composition containing paper mulberry extracts | |
| CN110090191B (en) | After-sun repair composition and cosmetic thereof | |
| CN109044941B (en) | Skin firming, nourishing and moisturizing composition and preparation method and application thereof | |
| CN104323969B (en) | A kind of nti-freckle antiphlogistic suncream and preparation method thereof | |
| CN108888562A (en) | A kind of eye mask and preparation method thereof | |
| KR101114161B1 (en) | Body Detergent composition for moisturizing or soothing the skin containing Aloe barbadensis miller extract and Althaea officinalis root extract | |
| CN106511211B (en) | Anti-inflammatory acne-removing skin-care lotion and preparation method thereof | |
| CN112516025A (en) | Plant extract composition cream with transdermal absorption effect and preparation method thereof | |
| KR102160978B1 (en) | Cosmetic materials composition for skin trouble care and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof | |
| CN116459169B (en) | Anti-inflammatory moisturizing skin external composition and preparation method and application thereof | |
| CN112057386A (en) | Refreshing, moisturizing, whitening and repairing sun block and preparation method thereof | |
| CN108938511B (en) | Composition of natural plant extracts and application of composition in skin moisturizing and acne removing products | |
| KR20080111249A (en) | Cosmetics Containing Chia Seed Extract | |
| CN102961275A (en) | Araliaceae Acanthopanax trifoliatus ethanol extract-containing skin cosmetic | |
| CN111184824A (en) | Freckle-removing traditional Chinese medicine liquid and preparation method thereof | |
| CN108938514B (en) | Skin-clearing acne-removing liquid and preparation method thereof | |
| CN110101587A (en) | A kind of anti-inflammatory anti-acne facial treatment milk | |
| CN108938543A (en) | A kind of lip treatments and preparation method thereof preventing and treating cheilitis | |
| KR102333132B1 (en) | Cosmetic Composition containing Frangipani Oil or Fermented Frangipani Oil |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 510000 floors 4-5, building 2, Yucai Road 12, Shiling Town, Huadu District, Guangzhou City, Guangdong Province Applicant after: Beiyouqing (Guangdong) Health Technology Co.,Ltd. Address before: 510000 floors 4-5, building 2, Yucai Road 12, Shiling Town, Huadu District, Guangzhou City, Guangdong Province Applicant before: GUANGZHOU COSE BIOTECHNOLOGY Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |